Margin Stability in Spotlight as MPHASIS Charts Measured Constant-Currency Growth
The IT services firm reports Q2 on November 5 after a Q1 that showed strong headline revenue momentum but compressed profitability. Street leans bullish; watch whether management can stabilize margins while sustaining organic growth.
The Setup: Margin Trajectory Is the Prize
MPHASIS reports Q2 FY27 on November 5. The real test: can the firm stabilize EBITDA and PAT margins after Q1's clear squeeze? The quarter showed 17.5% reported revenue growth (₹4,384 Cr, up sharply), but constant-currency growth of just 8.3%—the rupee did the heavy lifting. Worse, PAT grew only 11% YoY, signaling margin contraction. Management had flagged headwinds from currency, offshore-onshore cost mix, and deal ramp; three months later, we need to see whether pricing discipline and operational leverage are taking hold or whether the margin pressure is structural.
~₹4,500–4,550 Cr
17% YoY range; rupee strength visible in the gap between reported and CC growth
~8–10%
The organic baseline; Q1 was 8.3%. This is the watch metric for operational momentum.
Flat to +20 bps YoY
The swing factor—Q1 saw ~110 bps compression. Stabilization or further give signals execution risk.
~$400M+
Q1 closed $461M. Sustained velocity here signals client confidence and earnings sustainability.
A strong quarter shows steady 8–10% CC growth, PAT margin flat or +20 bps YoY (proof of leverage), and $400M+ deal wins on a sustained pipeline. A weak read signals further margin compression (PAT down YoY), CC growth falling below 7%, or deal velocity fading—each a red flag that client discretionary pullback or wage inflation is winning. Revenue at ₹4,550+ Cr would confirm the company is tracking full-year implied guidance.
On Track? FY27 Run-Rate
MPHASIS has offered no explicit full-year guidance, but the run-rate from Q1 (8.3% CC growth, ~₹4,380 Cr) and pre-result filings suggest the board is aiming for mid-single-digit organic growth with margin stability or slight expansion. The implicit challenge: rupee depreciation is boosting headline revenue but masking an otherwise modest earnings story. At the 35th AGM in July, the chairperson noted that enterprise hesitation around AI adoption and macro complexity are real headwinds. For a company with 40%+ promoter ownership and a traditionally strong operational discipline, the Q1 margin squeeze despite headline revenue momentum is the critical question. Is it a one-off ramp on large deals, or structural? Q2 will answer.
Since Last Quarter: Key Filings & Events
1 · ESG & Sustainability Upgrades (Aug–Oct 2026)
SBTi validation of near-term and net-zero GHG targets (Oct 22); NSE ESG rating of 75, Crisil ESG upgrade to 67, EcoVadis Silver Medal (75/100) for FY26. These credibility boosters matter for RFP conversations in regulated and ESG-conscious verticals.
2 · Social Security Scotland Contract Extended (Oct 6)
£35.4M extension to manage the UK's benefits platform. Not a mega-deal, but validates sticky client relationships in public-sector vertical and extends European earnings visibility.
3 · Income Tax Demand Revised Upward (Oct 14)
Tax demand for AY 2023–24 increased by ₹131 Cr to ₹2,417.80 Cr via rectification order. One-off, but signals tax risk and points to need for stronger internal controls. Watch for additional notices.
4 · Regulatory Fines (Jul 24)
BSE and NSE levied fines for SEBI Listing Rule 17(1) non-compliance in Q4 FY26. No material P&L impact, but flags governance slippage during rapid growth.
5 · TechnoPro Holdings Partnership (Sept 2)
Strategic agreement with Japan's largest tech staffing firm to co-deliver AI-powered enterprise solutions in Japan. A channel/distribution play signaling MPHASIS's AI positioning and geographic expansion strategy.
The mix: ESG credentials are strengthening (good for RFP win rates), client stickiness is visible (Social Security renewal), but tax and compliance headwinds are real and worth monitoring for precedent.
Watch List: Result Day Signals
1 · Margin trajectory
Is PAT margin flat or up YoY? Even +20 bps after Q1's 110 bps compression would signal a floor. Decline = caution on FY27 guidance.
2 · Constant-currency growth
Firm should disclose CC growth; 8–10% is on-plan, below 7% is a miss. This is the organic health metric.
3 · Deal pipeline & TCV
Q1 was $461M; $400M+ in Q2 confirms momentum. Miss here signals client caution.
4 · H2 outlook tone
Earnings call (Nov 6) will reveal confidence in margin recovery or a guidance tempering. Listen closely for commentary on forex, deal economics, and wage trends.
5 · Tax contingency disclosure
How much is provisioned for the ₹2.4 Cr tax demand? Any other notices pending?
6 · Shareholder returns
With strong cash and bullish analyst sentiment, any buyback or dividend surprise could re-rate the stock upward.
MPHASIS enters Q2 with strong technicals (price ₹2,525.6 above all major SMAs, RSI 57.3 neutral), recent analyst upgrades (Morgan Stanley Overweight to ₹3,500, Nuvama Buy at ₹3,200), and a consensus target of ₹3,038.91 (20% upside to ₹2,525.6). The Street is constructive on the FY27 trajectory. But operational delivery is what will move the needle post-result. Q1's headline revenue growth masked a modest CC growth story (8.3%) and margin compression—proving that rupee depreciation, not operational leverage, drove the headline beat. For MPHASIS to sustain the rally, it must prove it can grow 8–10% organically while stabilizing or expanding margins. Watch the earnings call tone for any reset on H2 or full-year guidance—that's where investors will make their call on whether the ₹3,000+ consensus is justified.